» Articles » PMID: 11278777

The Cdc42 Target ACK2 Directly Interacts with Clathrin and Influences Clathrin Assembly

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2001 Mar 30
PMID 11278777
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

The Ras-related GTP-binding protein Cdc42 has been implicated in a diversity of biological functions including the regulation of intracellular trafficking and endocytosis. While screening for Cdc42 targets that influence these activities, we identified the protein-tyrosine kinase ACK2 (for activated Cdc42-associated kinase 2) as a new binding partner for clathrin. ACK2 binds clathrin via a domain that is conserved among a number of other clathrin-binding proteins including the arrestins and AP-2. Overexpression of ACK2 in NIH3T3 cells results in an inhibition of transferrin receptor endocytosis because of a competition between ACK2 and AP-2 for clathrin. Activated Cdc42 weakens the interaction between ACK2 and clathrin and thus reverses the ACK2-mediated inhibition of endocytosis. Overexpression of ACK2 increases the amount of clathrin present in fractions enriched in clathrin-coated vesicles. Taken together, our data suggest that ACK2 may represent a novel clathrin-assembly protein and participate in the regulation of receptor-mediated endocytosis.

Citing Articles

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance.

Eshaq A, Flanagan T, Hassan S, Al Asheikh S, Al-Amoudi W, Santourlidis S Cancers (Basel). 2024; 16(15).

PMID: 39123481 PMC: 11311543. DOI: 10.3390/cancers16152754.


Domain Architecture of the Nonreceptor Tyrosine Kinase Ack1.

Kan Y, Paung Y, Seeliger M, Miller W Cells. 2023; 12(6).

PMID: 36980241 PMC: 10047419. DOI: 10.3390/cells12060900.


Held Up in Traffic-Defects in the Trafficking Machinery in Charcot-Marie-Tooth Disease.

Markworth R, Bahr M, Burk K Front Mol Neurosci. 2021; 14:695294.

PMID: 34483837 PMC: 8415527. DOI: 10.3389/fnmol.2021.695294.


Rational identification of a Cdc42 inhibitor presents a new regimen for long-term hematopoietic stem cell mobilization.

Liu W, Du W, Shang X, Wang L, Evelyn C, Florian M Leukemia. 2018; 33(3):749-761.

PMID: 30254339 PMC: 6414073. DOI: 10.1038/s41375-018-0251-5.


Sorting nexin 9 negatively regulates invadopodia formation and function in cancer cells.

Bendris N, Stearns C, Reis C, Rodriguez-Canales J, Liu H, Witkiewicz A J Cell Sci. 2016; 129(14):2804-16.

PMID: 27278018 PMC: 4958298. DOI: 10.1242/jcs.188045.